3.580USD+3.17%Mkt Cap: 38.49M USDP/E: 50.64Last update: 2026-05-26
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers …
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap38.49M USD
Enterprise Value37.01M USD
Revenue (TTM)19.12M USD
Gross Profit11.63M USD
Net Income (TTM)1.19M USD
Revenue/Share1.800 USD
Last Price3.580 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees36
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)50.64
P/E (Forward)36.90
PEG—
EV/EBITDA46.09
EV/Revenue1.94
P/S2.09
P/B3.74
EPS (TTM)0.07
EPS (Forward)0.10
52W Range
2.28031% of range6.420
52W High6.420 USD
52W Low2.280 USD
Profitability
Gross Margin61.87%
Oper. Margin1.86%
EBITDA Margin4.20%
Profit Margin6.35%
ROE11.70%
ROA8.75%
Growth
Revenue Growth6.90%
Earnings Growth-80.00%
Cash Flow & Leverage
Operating CF1.65M USD
CapEx (TTM)—
FCF Margin-4.04%
FCF Yield-2.01%
Net Debt-3.05M USD
Net Debt/EBITDA-3.80
Balance Sheet
Debt/Equity0.10
Current Ratio4.55
Quick Ratio2.98
Book Value/Sh0.9870 USD
Cash/Share0.3700 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 10, 2019
Splits
Last Split1:9
Split DateJul 10, 2019
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)7.000 USD
Target Range6.000 USD – 8.000 USD
# Analysts2
Ownership
Shares Out.10.86M
Float8.83M
Insiders11.10%
Institutions49.48%
Short Interest
Short Ratio1.3d
Short % Float0.45%
Short % Out.0.27%
Shares Short29.81K
Short (prev mo.)46.67K
Technical
SMA 503.106 (+15.3%)
SMA 2004.218 (-15.1%)
Beta1.47
S&P 52W Chg28.31%
Avg Vol (30d)31.92K
Avg Vol (10d)53.18K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—